Cranial implants market seen reaching $2.13 billion by 2030

The cranial implants market is projected to grow from $1.45 billion in 2026 to $2.13 billion by 2030, according to a new report from The Business Research Company. Demand is being driven by more neurological disease, more neurosurgical procedures and wider use of patient-specific and 3D-printed implants.

Why it matters: - Cranial implants are used to protect brain tissue, restore skull shape and support recovery after trauma or surgery. - The market outlook signals continued demand from hospitals, neurosurgeons and medical device makers as neurological disease rates rise. - The report points to faster adoption of patient-specific implants and additive manufacturing as a key shift in cranial reconstruction.

What happened: - The Business Research Company released its Cranial Implants Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on Aug. 3, 2026. - The report estimates the cranial implants market at $1.45 billion in 2026, up from $1.32 billion in 2025. - The company projects the market will reach $2.13 billion by 2030. - The report links the market to advances in medical technology and growing patient needs.

The details: - The market posted a 10.6% CAGR in the 2025-2026 period. - The forecast through 2030 implies a 10.0% CAGR. - Growth drivers include more traumatic brain injuries, more neurosurgical procedures, broader access to advanced implant materials, more reconstructive surgeries and stronger use of cranial reconstruction techniques. - The report also cites additive manufacturing, personalized healthcare demand, neurosurgical infrastructure expansion in emerging regions, improved surgical outcomes, new biomaterials and CAD/CAM design and manufacturing. - Cranial implants are described as supporting intracranial structures, normalizing cerebral blood flow and repairing cranial defects caused by trauma or surgery. - The report says neurological diseases affecting the brain, spinal cord and nerves are a major growth driver. - As of April 2024, NIH reported about 6.9 million Americans age 65 and older had Alzheimer’s dementia, with the number projected to reach 13.8 million by 2060. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The report offers a free sample and a full version through the company’s website: Download a free sample and View the full report.

Between the lines: - The forecast suggests the market is moving from steady growth into a more mature expansion phase, with personalization and manufacturing technology becoming as important as clinical need. - North America’s lead and Asia-Pacific’s expected growth point to a market that is already established in high-income health systems but still gaining scale in newer medical infrastructure markets. - The NIH dementia data underscores why demand for cranial reconstruction may keep rising even outside trauma cases.

What's next: - More adoption of 3D printing, CAD/CAM workflows and biocompatible materials should shape product development. - Emerging regions may see faster uptake as neurosurgical capacity and medical investment expand. - The report signals continued competition around implant fit, surgical precision and recovery outcomes.

The bottom line: - Cranial implants are set for double-digit growth through 2030, driven by rising neurological disease, more surgery and a shift toward customized implant technology.